The effects of schisandrin B (Sch B), curcumin, epigallocatechin gallate (EGCG) and resveratrol on the glutathione regeneration capacity (GRC) of liver and heart tissues ex vivo were examined in relation to their protective effects against CCl 4 hepatotoxicity in vivo and myocardial ischemia/reperfusion (I/R) injury ex vivo in rats. Results indicated that Sch B, but not curcumin, EGCG or resveratrol, caused hepatic and myocardial GRC enhancement, which was paralleled by its protection against CCl 4 hepatotoxicity and myocardial I/R injury. Although resveratrol and curcumin failed to increase the GRC of liver/heart tissues, they did protect against CCl 4 hepatotoxicity and myocardial I/R injury. In conclusion, the Sch B-induced enhancement of GRC ex vivo correlated well with its ability to protect tissues against oxidant injury in vivo/ex vivo, suggesting that the GRC assay can be used as a monitor of tissue protection for compounds stimulating glutathione redox cycling. However, phytochemicals can also protect against oxidant injury through various other mechanisms.
INTRODUCTION
Oxidative stress, an imbalance in redox status caused by an overproduction and/or inadequate scavenging of reactive oxygen species, was found to be associated with the aging process and a number of pathological conditions [1] . To counteract oxidative stress, reduced glutathione (GSH), the most abundant low molecular weight thiol in mammalian tissues, undergoes non-enzymatic and enzymatic reactions, during which GSH is converted to oxidized glutathione (GSSG) . Recent studies demonstrated that a pro-oxidant shift in the GSH/GSSG ratio is associated with age-related cell death, presumably due to the disruption of redox signaling cascades [2] . The maintenance of an optimal GSH/GSSG ratio is therefore critical for cell survival. To maintain the GSH/GSSG ratio under conditions of oxidative stress, cellular GSH can be regenerated from GSSG by a glutathione reductase (GR)-catalyzed reaction and/or be replenished by a two-step de novo synthesis involving glutamate cysteine ligase (GCL) and glutathione synthetase (GS) [3] . The ability of cells/tissues to replenish cellular GSH upon oxidative challenge is referred to as -glutathione recovery capacity‖ (GRC) [4] . In this connection, pharmacological interventions that can increase the GRC of cells or tissues offer a potential approach to protect against oxidant injury.
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of protecting against oxidant-induced injury. Thus, a growing number of dietary interventions have shown promise as inducers of nuclear factor erythroid 2-related factor 2 (Nrf2, a transcriptional regulator of antioxidant gene expression) that is capable of eliciting an antioxidant response [5] . Schisandrin B (Sch B) is the most abundant dibenzocyclooctadiene lignan isolated from Fructus Schisandrae (FS), a traditional Chinese herb that is clinically prescribed for the treatment of hepatitis. A previous study in our laboratory has demonstrated that treatment with a lignan-riched extract of FS increases the GRC of rat liver tissue homogenates ex vivo, presumably through the enhancement of GR-mediated GSH regeneration [4] . Consistent with this, we have recently shown that the extent of cytoprotection afforded by Sch B correlated with the degree of stimulation in GRC in various types of cultured cells, including AML12 hepatocytes, H9c2 cardiomyocytes and differentiated dopaminergic PC12 neuronal cells [6] . In particular, the resistance of Sch B-preincubated cells to tert-butylhydroperoxide (tBHP)-induced GSH depletion was significantly enhanced [6] . The cytoprotection afforded by Sch B against oxidant injury may be related to its ability to inhibit the depletion of cellular GSH and hence the irreversible process of apoptosis [7] .
Recently, the GRC assay ex vivo has been used as a bioactivity monitor for demonstrating the beneficial effect of a nanomized preparation of Sch B as compared with the conventional preparation in rat liver and heart tissues [8] . However, whether or not the enhancement of GRC can result in tissue protection against oxidant injury in vivo/ex vivo has yet to be established. In the present study, we examined the effect of Sch B on the GRC of liver and heart tissues in relation to its protective activity against CCl 4 -induced toxicity in liver and myocardial ischemia/reperfusion (I/R) injury in rats. The effects of curcumin, epigallocatechin gallate (EGCG) and resveratrol were also examined in order to investigate the possible role of glutathione redox cycling in protecting against oxidant injury by these compounds.
MATERIALS AND METHODS

Chemicals
Sch B was prepared as previously described [9] . Curcumin, EGCG, tBHP, 5,5'-Dithiobis(2-nitrobenzoic acid) (DTNB), GSH, GSSG, NADPH and NAD were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Resveratrol was obtained from Cayman Chemical Co. (Michigan, USA). All other chemicals were of analytical grade.
Animal Care
Adult Sprague-Dawley rats (8 to 10-week-old; 250 to 300 g) were maintained under a 12 h dark/light cycle at an ambient temperature of about 22 °C and allowed water and food ad libitum in the Animal and Plant Care Facility at the Hong Kong University of Science and Technology (HKUST). Experimental protocols were approved by the Research Practice Committee at the HKUST.
Animal Treatment
Animals were randomly divided into groups of five animals each. Previous studies have shown that treatment with Sch B (0.825 μmol/kg/day) for 15 consecutive days induced a glutathione antioxidant response and confer a protective effect in rat hearts [10] . In the study, rats were intragastrically administered Sch B, curcumin, EGCG or resveratrol (0.825 μmol/kg/day, 0.5 mL per rat) for 15 consecutive days. Control animals were treated with vehicle (0.5 mL olive oil) only. Twenty-four hours after the last dosing, the GRC of hepatic and myocardial tissue homogenates was measured. To investigate the effect of Sch B and other phytochemicals on tissue protection in vivo/ex vivo, rats were subjected to CCl 4 hepatotoxicity or myocardial I/R injury at the same time point (i.e., 24 h after the last dosing).
GRC Assay
Aliquots of 1 mL pre-warmed (in a water bath at 37 o C) liver and heart tissue homogenates were challenged with 1 mL tBHP (at final concentrations of 0.05 or 0.1 mM,) at 37 C for 60 min. At intervals of 0, 1, 10, 20, 30, 40, 50 and 60 min, a 200 μL aliquot of the reaction mixture was withdrawn and combined with 50 μL ice-cold trichloroacetic acid (25%, w/v). After centrifugation (2,500 ×g at 4 °C for 10 min), the supernatant was analyzed spectrophotometrically for acidsoluble free sulfhydryl group content, an indirect measure of GSH, using DTNB [11] . The GSH levels of samples were determined using a calibration curve. Data were normalized relative to the initial value of GSH (i.e. time = 0) of each sample and were expressed as % of the initial value. The GRC of each sample was estimated by computing the area under the curve (AUC) of the % initial value plotted against time, and expressed in arbitrary units.
CCl 4 Hepatotoxicity
Twenty-four hours after treatment with the putative protective agents, rats were given 1 mL/kg CCl 4 [10% (v/v) in olive oil] orally. Twenty-four hours after CCl 4 administration, rats were phenobarbtial-anesthetized and heparinized blood samples were drawn by cardiac puncture, and animals were then killed by cardiac excision. Plasma samples were obtained by centrifuging whole blood samples at 1,500 ×g for 10 min at 4 o C. The extent of hepatic oxidative damage was assessed by the measurement of plasma sorbitol dehydrogenase (SDH) activity as described previously [9] . The extent of protection against CCl 4 hepatotoxicity was estimated using the equation:
control ) × 100 %
Myocardial I/R Injury
Rat hearts isolated from phytochemical-pretreated rats were subjected to I/R challenge at 24 h following the last dosing. The excised hearts were retrogradely perfused according to the Langendorff method [12] . Isolated perfused rat hearts were subjected to 40 min of global ischemia followed by 20 min of reperfusion. The extent of lactate dehydrogenase (LDH) leakage during the reperfusion period, an indirect index of myocardial injury, was estimated by computing the area under the curve (AUC) of a graph plotting the percent LDH activity (with respect to the mean preischemic value measured during the equilibration period) against reperfusion time (1-20 min), as described previously, [12] and the value was expressed in arbitrary units. The degree of protection against myocardial I/R injury was estimated using the equation:
Protection (%) = [(LDH I/R control -LDH non-I/R control) -(LDH I/R drug -LDH non-I/R drug )]/(LDH I/R control -LDH non-I/R control ) × 100 %
Statistical Analysis
All data were expressed as mean ± standard error of the mean (SEM), unless otherwise specified. Data of the timedependent change in GSH levels in the GRC assay were analyzed by mixed analysis of variance (mixed ANOVA), while other data were analyzed by one-way analysis of variance (one-way ANOVA). Intergroup differences were detected by the Tukey multiple comparison test, when p < 0.05.
RESULTS
Effects of long-term, low dose treatment with Sch B and other phytochemicals on the GRC in rat liver and heart tissues ex vivo tBHP challenge caused oxidative stress in liver and heart tissues, as evidenced by a rapid depletion of GSH (46% at 0.25 min post-challenge and 61% at 10 min post-challenge), when compared with the initial GSH level (Fig. 1) . GSH restoration was observed in liver and heart tissues, with the extent of elevation being 67% (at 30 min post-challenge) and 48% (at 40 min post-challenge) of the initial level. Then, GSH levels began to decrease again. Sch B, but not curcumin, EGCG or resveratrol, significantly increased the GRC in liver and heart tissues, with the extent of increase being 30 and 16%, respectively. In contrast, EGCG reduced the GRC in heart tissue by 11%.
Effects of long-term, low dose treatment with Sch B and other phytochemicals on CCl 4 hepatotoxicity in vivo and ex vivo myocardial I/R injury ex vivo in rats CCl 4 induced oxidative injury in liver, as indicated by the increase in plasma SDH activity (7.7 fold), when compared with non-CCl 4 -challenged controls (Fig. 2) . Sch B and resveratrol, but not curcumin or EGCG, protected against Fig. (1) . Effects of long-term, low dose treatment with Sch B and other phytochemicals on glutathione recovery capacity (GRC) in rat liver and heart tissues ex vivo Rats were intragastrically administered Sch B, curcumin, EGCG or resveratrol (0.825 μmol/kg/day) for 15 consecutive days. Untreated control mice received oil (vehicle) only. Twenty-four hours after the last dosing, hepatic and myocardial tissue homogenates were challenged with tBHP at 0.1 and 0.05 mM (final concentrations), respectively. Time-dependent changes in GSH levels were monitored during the course of tBHP challenge. Data were expressed as % initial value by normalizing with initial GSH level (i.e. the value at time = 0) of the respective sample, and were analyzed by mixed analysis of variance (mixed ANOVA) (A). The GRC of each sample was estimated by computing the area under the curve (AUC) obtained by plotting % initial level against time (min), and expressed in arbitrary units (AU). Then, data were analyzed by one-way analysis of variance (one-way ANOVA) (B). Values given are means ± SEM, with n = 5 from two independent experiments. Intergroup differences were detected by Tukey multiple comparison, when p < 0.05. *significantly different from untreated control CCl 4 hepatotoxicity, with similar degrees of protection (62 and 65%, respectively).
I/R produced myocardial oxidative injury, as indicated by an increase in LDH leakage (7.9 fold), when compared with the non-I/R control group (Fig. 2) . Sch B and curcumin, but not EGCG or resveratrol, protected against myocardial I/R injury, with the degree of protection afforded by Sch B and curcumin being 34 and 52%, respectively.
DISCUSSION
Under conditions of oxidative stress, the rapid depletion of GSH can induce irreversible cell death/tissue damage [7] . In this regard, a sustained GRC (a manifestation of GSH replenishment) plays a pivotal role in rescuing cells/tissues from oxidative injury. In the present study, we sought to compare Sch B, curcumin, EGCG and resveratrol, which are inducers of an Nrf2-mediated antioxidant response [5] , on the GRC of liver and heart tissues in relation to their hepatoand cardio-protective effects against oxidant-induced injury. It was found that Sch B, but not curcumin, EGCG or resveratrol, enhanced the GRC of liver and heart tissues ex vivo, with the extent of GRC enhancement in the liver being more prominent than that in the heart. The stronger response from the liver may be attributed to higher levels of GSH and glutathione-related enzymes in liver tissue than those in heart tissue [13] . The enhancements in the GRC of liver and heart tissues produced by Sch-B treatment were found to parallel its protective effects against CCl 4 hepatotoxicity and myocardial I/R injury. These findings support our hypothesis that the Sch B-induced enhancement of GRC is crucial in rescuing cells from oxidant-induced tissue damage, which is associated with acute GSH depletion and the subsequent initiation of apoptosis.
GR-catalyzed GSH regeneration is important in maintaining an optimal ratio of GSH/GSSG during conditions of oxidative stress. Glucose-6-phosphate dehydrogenase (G6DPH) catalyzes the initial rate-limiting step in the pentose phosphate pathway, which generates the reducing cofactor NADPH, which is required for the GR-catalyzed regeneration of GSH. A cell-based study in our laboratory has found that -of the various phytochemicals investigatedonly Sch B (but not curcumin, EGCG or resveratrol) increased both GR and G6DPH activities in neuronal cells (unpublished data). This may involve a differential gene expression afforded by different Nrf2-activating phytochemicals. Despite the inability of resveratrol and curcumin to increase the GRC of liver and heart tissues, resveratrol and curcumin were found to protect against CCl 4 hepatotoxicity and myocardial I/R injury. This observation suggests that glutathione redox cycling may not be the sole protective mechanism against oxidant injury in cells and tissues. The release of pro-inflammatory cytokines, which is triggered by oxidative stress, was demonstrated to accompany liver damage such as that seen fibrosis and cirrhosis [14] . In this connection, a recent study has shown that treatment with Fig. (2) . Effects of long-term, low dose treatment with Sch B and other phytochemicals on CCl 4 hepatotoxicity and ex vivo myocardial I/R injury in rats Treatments were performed as described in Fig. 1 . To induce CCl 4 hepatotoxicity, rats were orally administered CCl 4 (1 mL/kg) at 24 hours after the last dosing with phytochemical. At 24 hours post-CCl 4 administration, plasma SDH activity was measured (A). To induce myocardial I/R injury, isolated rat hearts were subjected to 40 min of global ischemia followed by 20 min reperfusion at 24 hours after the last dosing. The extent of myocardial I/R injury was assessed by the measurement of LDH leakage (B). Value given are means ± SEM, with n = 5 from two independent experiments. Data were analyzed by one-way analysis of variance (one-way ANOVA), and the intergroup differences were detected by Tukey multiple comparison, when p < 0.05. resveratrol protected against CCl 4 hepatotoxicity in rats via the suppression of fibrogenic cytokine release [15] . Similarly, curcumin treatment was found to ameliorate myocardial I/R injury in rats through the inhibition of a toll-like receptor-2-mediated inflammatory response [16] .
In conclusion, the Sch B-induced enhancement of GRC ex vivo paralleled with tissue protection against oxidant injury in vivo/ex vivo, suggesting that the GRC assay ex vivo can be used for screening compounds capable of stimulating glutathione redox cycling and thus protect against oxidant injury. However, our results suggest that phytochemicals can also protect against oxidant injury through different mechanisms of action.
